SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patient...

by Campo, R., DeJesus, E., Bredeek, U. F., Henry, K., Khanlou, H., Logue, K., Brinson, C., Benson, P., Dau, L., Wang, H., White, K., Flaherty, J., Fralich, T., Guyer, B., Piontkowsky, D.
Published 2013